Core Viewpoint - Morgan Stanley is expected to announce its second-quarter 2025 earnings on July 16, with analysts and investors closely monitoring the performance amid the implications of Trump's tariff plans [1] Financial Performance - The first-quarter performance was strong, driven by solid investment banking and trading results, with second-quarter revenue estimates at $15.92 billion, reflecting a 6% year-over-year growth [2] - The consensus estimate for earnings in the upcoming quarter has been revised down by 1.5% to $1.93, indicating a 6% improvement from the previous year's quarter [2][4] Earnings Surprise History - Morgan Stanley has a strong history of earnings surprises, having exceeded the Zacks Consensus Estimate in the last four quarters with an average beat of 20.3% [4] Factors Impacting Q2 Earnings - Investment Banking (IB) income is projected to decline year-over-year despite a stronger IPO market, with advisory fees estimated at $538 million, down 9.1% from the previous year [6][8] - Trading revenues are expected to surge due to market volatility, with equity trading revenues estimated at $3.46 billion, a 14.8% increase year-over-year [7][13] - Net interest income is projected to grow by 9.8% year-over-year to $2.27 billion, supported by stable rates and solid loan growth [14][15] Underwriting Fees - The consensus estimate for total underwriting fees is $884 million, indicating a decline of 13.9% year-over-year, with fixed-income underwriting fees expected to fall by 17% [10][11] Cost Management - Total non-interest expenses are anticipated to rise by 6.6% year-over-year to $11.6 billion, as the company continues to invest in its franchises [16] Price Performance - In the second quarter, Morgan Stanley's stock performance was strong, outperforming the Zacks Investment Bank industry and the S&P 500 Index, although it lagged behind Goldman Sachs [20]

The market expects Crown Holdings (CCK) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released ...

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for W.R. Berkley despite higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - W.R. Berkley is expected to report quarterly earnings of $1.03 per share, reflecting a -1% change year-over-year, while revenues are projected at $3.58 billion, a 6% increase from the previous year [3]. - The consensus EPS estimate has been revised down by 0.47% over the last 30 days, indicating a bearish sentiment among analysts [4]. Earnings Surprise Prediction - The Most Accurate Estimate for W.R. Berkley is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.46%, complicating predictions for an earnings beat [12]. - The stock holds a Zacks Rank of 3, which does not strongly support a positive earnings surprise prediction [12]. Historical Performance - In the last reported quarter, W.R. Berkley met the expected earnings of $1.01 per share, showing no surprise [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Industry Comparison - Selective Insurance, another player in the insurance sector, is expected to post earnings of $1.55 per share, indicating a significant year-over-year change of +240.9%, with revenues projected at $1.31 billion, up 9.7% [19]. - Despite a higher Most Accurate Estimate leading to an Earnings ESP of +1.94%, Selective Insurance has a Zacks Rank of 4, making it difficult to predict an earnings beat [20].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Domino's Pizza despite higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Domino's Pizza is expected to report quarterly earnings of $3.93 per share, reflecting a -2.5% change year-over-year, while revenues are projected at $1.14 billion, an increase of 3.9% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.23% higher in the last 30 days, indicating a slight positive reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Domino's is lower than the consensus estimate, resulting in an Earnings ESP of -0.27%, suggesting a bearish outlook from analysts [12]. Historical Performance - In the last reported quarter, Domino's exceeded expectations with earnings of $4.33 per share against an anticipated $4.12, achieving a surprise of +5.10% [13]. Over the last four quarters, the company has beaten consensus EPS estimates three times [14]. Investment Considerations - Despite the potential for an earnings beat, other factors may influence stock performance, making it essential to consider the Earnings ESP and Zacks Rank before the earnings release [15][16].

Core Viewpoint - The market anticipates Medpace (MEDP) will report a year-over-year increase in earnings driven by higher revenues in its upcoming earnings report for the quarter ended June 2025 [1][3]. Earnings Expectations - The consensus EPS estimate for Medpace is $3.00 per share, reflecting a year-over-year increase of +9.1% [3]. - Expected revenues for the quarter are $541.19 million, which is a 2.5% increase from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 0.81%, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Medpace is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.91%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with positive readings being more reliable [9][10]. - Medpace currently holds a Zacks Rank of 3, which complicates the prediction of an earnings beat given the negative Earnings ESP [12]. Historical Performance - In the last reported quarter, Medpace exceeded the expected earnings of $3.06 per share by delivering $3.67, resulting in a surprise of +19.93% [13]. - The company has successfully beaten consensus EPS estimates in the last four quarters [14]. Conclusion - While Medpace does not appear to be a strong candidate for an earnings beat based on current estimates, investors should consider other factors before making investment decisions [17].

Core Insights - PepsiCo, Inc. is anticipated to report declines in both revenue and earnings for the second quarter of 2025, with revenues expected at $22.4 billion, reflecting a 0.5% year-over-year decrease, and earnings per share (EPS) projected at $2.04, indicating a 10.5% decline from the previous year [1][2][10] Financial Performance - The Zacks Consensus Estimate for second-quarter revenues is $22.4 billion, down 0.5% from the same quarter last year [2] - The consensus estimate for quarterly earnings is $2.04, suggesting a 10.5% decline from the $2.28 reported in the prior-year quarter [2] - The company experienced a negative earnings surprise of 1.3% in the last reported quarter, with an average earnings surprise of 1.4% over the trailing four quarters [2] Operational Challenges - PepsiCo is facing multiple headwinds, particularly in its North America operations, which have been struggling since early 2024 due to underwhelming results in the PepsiCo Foods North America (PFNA) segment and a decline in Asia Pacific Foods [5][10] - The weakness in the PFNA segment is largely attributed to reduced demand for Frito-Lay products as consumers become more inflation-conscious and cut back on discretionary spending [6][7] - Consumer sentiment remains cautious, with inflationary pressures leading to more value-driven purchasing behavior, particularly in North America [7] Cost Environment - The company is contending with a challenging cost environment in 2025, driven by rising supply-chain expenses and increased tariffs on globally sourced inputs [8][9] - Incremental cost pressures related to sourcing key ingredients and materials are exacerbated by shifting international trade dynamics [8] - The combination of escalating global logistics costs and geopolitical uncertainty is disrupting pricing and procurement strategies, potentially eroding margins [9] Profitability Outlook - PepsiCo's second-quarter results are expected to reflect margin pressure due to the timing and phasing of productivity initiatives, with adjusted gross profit anticipated to decline by 0.8% year-over-year and adjusted operating income expected to fall by 9.6% [11][12] - Despite ongoing cost discipline, the company's core profitability appears temporarily constrained due to elevated supply-chain costs and tariff-related headwinds [11] Growth Drivers - PepsiCo benefits from a strong core product portfolio, diversified operations, modernized supply chain, and enhanced digital capabilities, with its international business contributing approximately 40% to total net revenues [13] - The International Beverages Franchise segment is projected to see a 2% year-over-year revenue improvement in the second quarter of 2025 [14] - The company aims to achieve productivity goals through savings from restructuring actions, which are expected to drive top-line growth and improve margins [14] Stock Performance and Valuation - PepsiCo shares have underperformed in the past three months, losing 7.3%, compared to a 5.2% decline in the broader industry and a 1.1% decline in the Consumer Staples sector [15] - The stock is currently trading at a forward P/E ratio of 16.83X, which is below the S&P 500's average of 22.64X and the broader industry's average of 18X [20] - The valuation on a forward 12-month P/E basis reflects a significant discount to the market, although this may indicate underlying issues rather than a clear investment opportunity [22] Investment Outlook - Despite consistent revenue growth and strong profitability driven by a diverse product portfolio, external risks such as inflationary pressures and operational challenges in North America warrant a cautious investment outlook [23][24] - The company’s strong international momentum, investments in digital transformation, and product innovation may serve as meaningful tailwinds [26] - A wait-and-watch approach may be prudent as investors assess how the company navigates current challenges and leverages growth drivers post-earnings [27]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Abbott, driven by higher revenues, with a focus on how actual results will compare to estimates [1][2]. Earnings Expectations - Abbott is expected to report quarterly earnings of $1.25 per share, reflecting a +9.7% change year-over-year, with revenues projected at $11.07 billion, up 6.7% from the previous year [3]. - The earnings report is scheduled for July 17, and better-than-expected results could lead to a stock price increase, while a miss may result in a decline [2]. Estimate Revisions - The consensus EPS estimate has been revised 0.44% lower in the last 30 days, indicating a reassessment by analysts [4]. - A positive Earnings ESP of +0.96% suggests analysts have recently become more optimistic about Abbott's earnings prospects, combined with a Zacks Rank of 2 indicating a likely earnings beat [12]. Earnings Surprise History - Abbott has a history of beating consensus EPS estimates, having exceeded expectations in three out of the last four quarters [14]. - In the last reported quarter, Abbott's earnings of $1.09 per share surpassed the expected $1.07, resulting in a surprise of +1.87% [13]. Conclusion - Abbott is positioned as a strong candidate for an earnings beat, but investors should consider additional factors beyond earnings results when making investment decisions [15][17].

Core Viewpoint - The market anticipates Elevance Health (ELV) will report a year-over-year decline in earnings despite higher revenues in its upcoming earnings report for the quarter ended June 2025 [1] Earnings Expectations - Elevance Health is expected to post quarterly earnings of $9.20 per share, reflecting a year-over-year decrease of 9.1% [3] - Revenues are projected to reach $48.13 billion, representing an increase of 11.4% compared to the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a stable outlook from covering analysts [4] - The Most Accurate Estimate for Elevance Health is lower than the Zacks Consensus Estimate, leading to an Earnings ESP of -5.05%, suggesting a bearish sentiment among analysts [12] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with positive readings being more reliable [9][10] - A positive Earnings ESP combined with a Zacks Rank of 1, 2, or 3 has shown a nearly 70% success rate in predicting earnings beats [10] Historical Performance - In the last reported quarter, Elevance Health exceeded expectations by delivering earnings of $11.97 per share against an expected $11.21, resulting in a surprise of +6.78% [13] - Over the past four quarters, the company has beaten consensus EPS estimates three times [14] Conclusion - While Elevance Health does not currently appear to be a strong candidate for an earnings beat, investors should consider other influencing factors when making investment decisions ahead of the earnings release [17]

Core Viewpoint - The market anticipates U.S. Bancorp (USB) will report a year-over-year increase in earnings and revenues for the quarter ended June 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - U.S. Bancorp is expected to post quarterly earnings of $1.07 per share, reflecting a year-over-year increase of +9.2% [3]. - Revenues are projected to be $7.06 billion, which is a 3.2% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 0.67% over the last 30 days, indicating a reassessment by analysts [4]. - Despite the downward revision, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +0.08% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - U.S. Bancorp currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, U.S. Bancorp exceeded the expected earnings of $0.99 per share by delivering $1.03, resulting in a surprise of +4.04% [13]. - The company has beaten consensus EPS estimates in each of the last four quarters [14]. Industry Comparison - The Bank of New York Mellon Corporation (BK), another player in the Zacks Banks - Major Regional industry, is expected to report earnings of $1.74 per share, reflecting a year-over-year change of +15.2% [18]. - BK's revenues are expected to be $4.86 billion, up 5.6% from the previous year, with a positive Earnings ESP of +1.03% and a Zacks Rank of 2 [19][20].

Core Viewpoint - The market anticipates Webster Financial (WBS) will report a year-over-year increase in earnings driven by higher revenues for the quarter ended June 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected to be released on July 17, with a consensus EPS estimate of $1.43, reflecting a year-over-year increase of +13.5%. Revenues are projected at $712.23 million, up 15.9% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their initial projections during this period [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model compares the Most Accurate Estimate to the Zacks Consensus Estimate, suggesting that recent analyst revisions may provide more accurate insights into earnings expectations [8][9]. Current Earnings ESP and Zacks Rank - For Webster Financial, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.50%. The stock currently holds a Zacks Rank of 3, complicating predictions for an earnings beat [12]. Historical Performance - In the last reported quarter, Webster Financial was expected to post earnings of $1.38 per share but delivered only $1.30, resulting in a surprise of -5.80%. Over the past four quarters, the company has only beaten consensus EPS estimates once [13][14]. Conclusion - While the company may not appear to be a strong candidate for an earnings beat, investors should consider other factors when making decisions regarding the stock ahead of the earnings release [17].